At FIP 2026, which will take place in Lyon from 2-5th June, Netstal will present an integrated production solution for the highly efficient series production of autoinjector housings for the administration of GLP-1 drugs.
Beccy Bell, operations director at testing and regulatory specialist Broughton, examines how stability study management shifts as data moves beyond contained documentation and begins to inform decisions for products already on the market.
NunaBio, a next-gen DNA manufacturing company, has secured £6.5 million in funding to scale-up its DNA platform and accelerate its continued growth as a commercially focused infrastructure business for synthetic biology, therapeutics, and research.
Ray Niemeyer, vice president of sales at SpaceGuard Products explains the importance of durable guarding and rack protection systems in cold storage and cleanroom environments.
TekniPlex Healthcare, which utilises advanced materials science expertise to help deliver better patient outcomes, will exhibit and present at The Pharma Days 2026, taking place 27-28th May at Palexpo in Geneva, Switzerland.
Ampersand Capital Partners, a private equity firm with deep operational expertise scaling life sciences and healthcare companies, announced it has completed the sale of Tjoapack to Alcami Corporation.
Matt Cokely, global technical consultant director at Ecolab explores how rapid recovery in a GMP environment means restoring control through predefined, risk-based and inspection-defensible strategies that protect sterility assurance under pressure.
Vetter, a Contract Development and Manufacturing Organisation (CDMO), is celebrating the start of construction on its new site in Saarlouis with a traditional groundbreaking ceremony.
Emerson has announced major advancements to the AspenTech Inmation OT Data Fabric, establishing it as the foundational enterprise-scale intelligence layer for the AspenTech Inmation Data Platform.
